Article Abstract

The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer

Authors: Chong-Kin Liam

Abstract

Activating mutations in the epidermal growth factor receptor (EGFR) gene is the most common driver oncogene in non-small cell lung cancer (NSCLC), being present in up to 60% of Asian patients and up to 20% in Caucasian patients with advanced NSCLC.

Article Options

Download Citation